- Home
- BMR vs CALC Comparison
BMR vs CALC Comparison
Compare BMR & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- CALC
- Stock Information
- Founded
- BMR 2009
- CALC 2011
- Country
- BMR Israel
- CALC United States
- Employees
- BMR N/A
- CALC N/A
- Industry
- BMR Computer Software: Prepackaged Software
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- CALC Health Care
- Exchange
- BMR Nasdaq
- CALC Nasdaq
- Market Cap
- BMR 47.4M
- CALC 45.4M
- IPO Year
- BMR 2023
- CALC N/A
- Fundamental
- Price
- BMR $2.17
- CALC $4.04
- Analyst Decision
- BMR
- CALC Strong Buy
- Analyst Count
- BMR 0
- CALC 2
- Target Price
- BMR N/A
- CALC $14.50
- AVG Volume (30 Days)
- BMR 123.0K
- CALC 90.0K
- Earning Date
- BMR 08-13-2025
- CALC 11-12-2025
- Dividend Yield
- BMR N/A
- CALC N/A
- EPS Growth
- BMR N/A
- CALC N/A
- EPS
- BMR N/A
- CALC N/A
- Revenue
- BMR $3,131,000.00
- CALC N/A
- Revenue This Year
- BMR $21.21
- CALC N/A
- Revenue Next Year
- BMR N/A
- CALC N/A
- P/E Ratio
- BMR N/A
- CALC N/A
- Revenue Growth
- BMR 5.96
- CALC N/A
- 52 Week Low
- BMR $1.86
- CALC $1.42
- 52 Week High
- BMR $6.59
- CALC $4.50
- Technical
- Relative Strength Index (RSI)
- BMR 44.83
- CALC 69.98
- Support Level
- BMR $1.89
- CALC $3.03
- Resistance Level
- BMR $2.05
- CALC $4.49
- Average True Range (ATR)
- BMR 0.14
- CALC 0.32
- MACD
- BMR 0.02
- CALC 0.12
- Stochastic Oscillator
- BMR 64.04
- CALC 75.59
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.